04:00 , Jan 4, 2019 |  BC Week In Review  |  Financial News

Suzhou Connect raises $55M series B, plans Phase Ib of dermatitis candidate

Suzhou Connect Biopharmaceuticals Ltd. (Taicang, China) raised $55 million on Jan. 2 in a series B round led by new investor Advantech Capital and announced plans to start a Phase Ib trial this quarter of...
01:06 , Jan 3, 2019 |  BC Extra  |  Financial News

Suzhou Connect raises $55M series B, plans Phase Ib of dermatitis candidate

Suzhou Connect Biopharmaceuticals Ltd. (Taicang, China) raised $55 million in a series B round Wednesday led by new investor Advantech Capital and announced plans to start a Phase Ib trial this quarter of its second...
00:53 , Jan 26, 2017 |  BC Extra  |  Financial News

Connect raises $20M series A round

Connect Biopharmaceuticals Ltd. (Suzhou, China) said it raised $20 million in an oversubscribed series A round led by Qiming Venture Partners. Also participating were Northern Light Venture Capital, Lapan Capital and Cowin Venture Capital. The...